J. Goldman & Co’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

J. Goldman & Co’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200,000	Closed	-$17.9M	–	388
2019 Q4	$17.9M	Hold	200,000	–	–	1.29%	11
2019 Q3	$17M	Hold	200,000	–	–	1.28%	14
2019 Q2	$15.2M	Hold	200,000	–	–	1.05%	20
2019 Q1	$15.7M	Hold	200,000	–	–	0.89%	25
2018 Q4	$15.1M	Buy	+200,000	New	+$99.3K	1.17%	16

J. Goldman & Co's GCVRZ Position: Q3 2018 in Review

J. Goldman & Co sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2018, closing a stake of 200,000 shares — an estimated $101K sold.

J. Goldman & Co first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $525K in Q3 2013. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2018.

J. Goldman & Co reported no remaining Sanofi Contingent Value Rights position as of Q3 2018 after selling out during the quarter.
J. Goldman & Co sold 200,000 Sanofi Contingent Value Rights shares in Q3 2018, an estimated $101K.
J. Goldman & Co first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
J. Goldman & Co's Sanofi Contingent Value Rights position peaked at $525K in Q3 2013.
106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2018.

Based on J. Goldman & Co's 13F filing for Q3 2018, filed 14 Nov 2018.